Insider · CIK 0001830371
Mark Bodenrader
Files at CERE (Cerevel Therapeutics Holdings, Inc.). First filing Dec 21, 2023, latest Dec 21, 2023.
In brief
Mark Bodenrader files SEC Form 4 as officer at CERE (Cerevel Therapeutics Holdings, Inc.). Since Dec 21, 2023, Mark Bodenrader has reported 0 open-market buys worth $0 and 1 open-market sell worth $327k, the latest filed on Dec 21, 2023.
A track record needs three past buys with six months of prices behind them; Mark Bodenrader has 0, so none is measured yet.
The newest scored trade: sold $327k of CERE on Dec 20, 2023, filed Dec 21, 2023, scored 40 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Cerevel Therapeutics Holdings, Inc. | $327k 7,889 shares | -31% | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 19, 2024 | CERE Cerevel Therapeutics Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +24,852 | $0.00 | $0 | 24,852 | Jan 23, 2024 |
| Dec 19, 2023 | CERE Cerevel Therapeutics Holdings, Inc. | MOption exercise Common Stock | +14,199 | - | - | 20,528 | Dec 21, 2023 |
| Dec 19, 2023 | CERE Cerevel Therapeutics Holdings, Inc. | MOption exercise Common Stock | +5,085 | - | - | 25,613 | Dec 21, 2023 |
| Dec 20, 2023 | CERE Cerevel Therapeutics Holdings, Inc. | SOpen-market sale Common Stock | -7,889 | $41.42 | $327k | 17,724 | Dec 21, 2023 |
| Dec 19, 2023 | CERE Cerevel Therapeutics Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -14,199 | $0.00 | $0 | 0 | Dec 21, 2023 |
| Dec 19, 2023 | CERE Cerevel Therapeutics Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -5,085 | $0.00 | $0 | 0 | Dec 21, 2023 |
Questions about Mark Bodenrader
Answered from the filings on this page, as of the latest one.
Is Mark Bodenrader buying or selling?
Not in the last 12 months. Mark Bodenrader's latest open-market trade on SEC Form 4 was sold $327k of CERE on Dec 20, 2023.
How did Mark Bodenrader's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark Bodenrader has 0.
Where does Mark Bodenrader file Form 4?
Mark Bodenrader has filed Form 4 at CERE (Cerevel Therapeutics Holdings, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.